| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).
|
Circulation
|
2000
|
7.37
|
|
2
|
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
|
Diabetes
|
2002
|
4.58
|
|
3
|
Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.
|
Diabetes
|
1996
|
4.20
|
|
4
|
Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
|
Circulation
|
1996
|
3.88
|
|
5
|
The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results.
|
Ann Epidemiol
|
1995
|
3.24
|
|
6
|
Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study.
|
JAMA
|
1998
|
2.56
|
|
7
|
Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods.
|
Ann Epidemiol
|
2003
|
2.51
|
|
8
|
Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.
|
Diabetes
|
2003
|
2.22
|
|
9
|
Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study.
|
Diabetes
|
2003
|
2.22
|
|
10
|
Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study.
|
Arterioscler Thromb Vasc Biol
|
2003
|
2.12
|
|
11
|
Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
|
Circulation
|
2005
|
2.08
|
|
12
|
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
|
Diabetes
|
2004
|
2.08
|
|
13
|
Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.
|
Metabolism
|
2005
|
1.77
|
|
14
|
Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study.
|
Diabetes Care
|
2004
|
1.74
|
|
15
|
A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study.
|
Diabetes
|
1994
|
1.73
|
|
16
|
Ethnic and racial differences in diabetes care: The Insulin Resistance Atherosclerosis Study.
|
Diabetes Care
|
2003
|
1.64
|
|
17
|
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.
|
Kidney Int
|
2000
|
1.62
|
|
18
|
Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS)
|
Am J Clin Nutr
|
1997
|
1.59
|
|
19
|
Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study.
|
Diabetes
|
1996
|
1.53
|
|
20
|
Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
|
Arterioscler Thromb Vasc Biol
|
1997
|
1.53
|
|
21
|
Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study.
|
Diabetes
|
1998
|
1.45
|
|
22
|
Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study.
|
Stroke
|
1996
|
1.42
|
|
23
|
Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.
|
Diabetes
|
1997
|
1.42
|
|
24
|
Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study.
|
Diabetes
|
2002
|
1.42
|
|
25
|
Whole-grain intake and insulin sensitivity: the Insulin Resistance Atherosclerosis Study.
|
Am J Clin Nutr
|
2003
|
1.41
|
|
26
|
Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study.
|
Diabetes
|
2002
|
1.38
|
|
27
|
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
|
Arterioscler Thromb Vasc Biol
|
1999
|
1.37
|
|
28
|
Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.
|
Diabetes Care
|
1999
|
1.36
|
|
29
|
Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS).
|
Stroke
|
1997
|
1.25
|
|
30
|
Identification of quantitative trait loci for glucose homeostasis: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study.
|
Diabetes
|
2004
|
1.25
|
|
31
|
Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study.
|
Hum Genet
|
2005
|
1.21
|
|
32
|
Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study.
|
Diabetes Care
|
1998
|
1.21
|
|
33
|
Dietary patterns, insulin sensitivity and adiposity in the multi-ethnic Insulin Resistance Atherosclerosis Study population.
|
Br J Nutr
|
2004
|
1.17
|
|
34
|
Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
|
Circulation
|
2003
|
1.15
|
|
35
|
Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study.
|
Hypertension
|
2004
|
1.15
|
|
36
|
Linkage of the metabolic syndrome to 1q23-q31 in Hispanic families: the Insulin Resistance Atherosclerosis Study Family Study.
|
Diabetes
|
2004
|
1.14
|
|
37
|
Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators.
|
Ann Epidemiol
|
1998
|
1.13
|
|
38
|
Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study.
|
Diabetes Care
|
2000
|
1.11
|
|
39
|
Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
|
Diabetes Care
|
2004
|
1.10
|
|
40
|
Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.
|
Circulation
|
2004
|
1.09
|
|
41
|
Duration of diabetes and carotid wall thickness. The Insulin Resistance Atherosclerosis Study (IRAS).
|
Stroke
|
1997
|
1.08
|
|
42
|
Quantitative trait loci for abdominal fat and BMI in Hispanic-Americans and African-Americans: the IRAS Family study.
|
Int J Obes (Lond)
|
2005
|
1.06
|
|
43
|
The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study.
|
Diabetologia
|
1999
|
1.05
|
|
44
|
Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study.
|
Diabetes Care
|
2004
|
1.04
|
|
45
|
Carotid artery atherosclerosis in type-2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atherosclerosis Study).
|
Am J Cardiol
|
2000
|
1.03
|
|
46
|
Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis Study.
|
Diabetes Care
|
2003
|
1.03
|
|
47
|
Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
|
Metabolism
|
1998
|
1.03
|
|
48
|
Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS).
|
Circulation
|
2003
|
1.01
|
|
49
|
Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS).
|
Stroke
|
1999
|
1.01
|
|
50
|
Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS).
|
Diabetes Care
|
2002
|
1.00
|
|
51
|
Association of adipose tissue deposition and beta-2 adrenergic receptor variants: the IRAS family study.
|
Int J Obes (Lond)
|
2005
|
0.99
|
|
52
|
Metabolic predictors of 5-year change in weight and waist circumference in a triethnic population: the insulin resistance atherosclerosis study.
|
Am J Epidemiol
|
2003
|
0.99
|
|
53
|
Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. The Insulin Resistance Atherosclerosis Study.
|
Am J Epidemiol
|
1995
|
0.98
|
|
54
|
C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study.
|
Diabet Med
|
2002
|
0.97
|
|
55
|
Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?
|
Diabetes Care
|
2003
|
0.96
|
|
56
|
Site-specific progression of carotid artery intimal-medial thickness.
|
Atherosclerosis
|
2003
|
0.94
|
|
57
|
Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS).
|
Diabetes Obes Metab
|
2005
|
0.94
|
|
58
|
Pleiotropy and heterogeneity in the expression of atherogenic lipoproteins: the IRAS Family Study.
|
Hum Hered
|
2003
|
0.92
|
|
59
|
A genome scan for fasting insulin and fasting glucose identifies a quantitative trait locus on chromosome 17p: the insulin resistance atherosclerosis study (IRAS) family study.
|
Diabetes
|
2005
|
0.92
|
|
60
|
Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects.
|
Diabetes Care
|
2000
|
0.91
|
|
61
|
Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study.
|
Diabetes
|
2004
|
0.90
|
|
62
|
Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.
|
Diabetes Care
|
1998
|
0.90
|
|
63
|
Insulin secretion, obesity, and potential behavioral influences: results from the Insulin Resistance Atherosclerosis Study (IRAS).
|
Diabetes Metab Res Rev
|
2001
|
0.89
|
|
64
|
Is insulin sensitivity a causal intermediate in the relationship between alcohol consumption and carotid atherosclerosis?: the insulin resistance and atherosclerosis study.
|
Diabetes Care
|
2002
|
0.87
|
|
65
|
Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study.
|
Arterioscler Thromb Vasc Biol
|
1999
|
0.87
|
|
66
|
Insulin sensitivity, body fat distribution, and family diabetes history: the IRAS Family Study.
|
Obes Res
|
2004
|
0.85
|
|
67
|
Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study.
|
Stroke
|
1998
|
0.84
|
|
68
|
LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.
|
Diabetes Care
|
1999
|
0.83
|
|
69
|
Longitudinal decline of β-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study.
|
J Clin Endocrinol Metab
|
2013
|
0.82
|
|
70
|
Differences in LDL oxidizability by glycemic status: the insulin resistance atherosclerosis study.
|
Diabetes Care
|
2003
|
0.81
|
|
71
|
Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study.
|
Diabetes Care
|
2000
|
0.79
|
|
72
|
Vitamin C intake and cardiovascular disease risk factors in persons with non-insulin-dependent diabetes mellitus. From the Insulin Resistance Atherosclerosis Study and the San Luis Valley Diabetes Study.
|
Prev Med
|
1997
|
0.78
|
|
73
|
Association analysis of the plasminogen activator inhibitor-1 4G/5G polymorphism in Hispanics and African Americans: the IRAS family study.
|
Hum Hered
|
2004
|
0.77
|
|
74
|
Cosegregation of albuminuria and blood pressure: the Insulin Resistance Atherosclerosis (IRAS) family study.
|
Am J Hypertens
|
2005
|
0.76
|
|
75
|
Insulin sensitivity and intake of vitamins E and C in African American, Hispanic, and non-Hispanic white men and women: the Insulin Resistance and Atherosclerosis Study (IRAS).
|
Am J Clin Nutr
|
1997
|
0.75
|